Attend the 4th Annual Clinical Site Partnerships in Central & Eastern Europe in September 7-8,2009 at Hotel Marriott,Budapest,Hungary.
Central & Eastern Europe continues to be one of the most attractive regions globally for running clinical trials. With its substantial pool of patients, centralized healthcare system and highly motivated investigators it still offers time, cost and quality advantages over other territories.
This event will build upon our previous meetings by examining in detail the current clinical landscape impacting clinical trials in the CEE & CIS region, dealing with longstanding regulatory obstacles, site selection and performance hurdles, approaches to ensure the quality and integrity of data and improving understanding of clinical trials amongst the region’s population. Particular attention will also be given to the continuing barriers to improvements in EU member states as well as Russia, Ukraine and the Balkan regions via focused conference sessions.
NextLevel Pharma's "Clinical Site Partnerships in Central & Eastern Europe" event is the only meeting which provides the opportunity to participate in 1 on 1 partnering sessions enabling trial sponsor companies, CROs, clinical solution providers, and sites themselves to meet with one another to discuss potential partnerships.
Central & Eastern Europe continues to be one of the most attractive regions globally for running clinical trials. With its substantial pool of patients, centralized healthcare system and highly motivated investigators it still offers time, cost and quality advantages over other territories.
This event will build upon our previous meetings by examining in detail the current clinical landscape impacting clinical trials in the CEE & CIS region, dealing with longstanding regulatory obstacles, site selection and performance hurdles, approaches to ensure the quality and integrity of data and improving understanding of clinical trials amongst the region’s population. Particular attention will also be given to the continuing barriers to improvements in EU member states as well as Russia, Ukraine and the Balkan regions via focused conference sessions.
NextLevel Pharma's "Clinical Site Partnerships in Central & Eastern Europe" event is the only meeting which provides the opportunity to participate in 1 on 1 partnering sessions enabling trial sponsor companies, CROs, clinical solution providers, and sites themselves to meet with one another to discuss potential partnerships.
Who will benefit:
Pharmaceutical & Biotechnology Organisations:
Global / European / Regional / Country Heads of Clinical Operations, Clinical Development, Outsourcing, Contract Management, Risk Management, R&D Sourcing, Business Development. Project Managers, Study Managers, and Senior CRAs,
CROs & Clinical Solution Providers:
CEOs, Business Development Directors, Product Managers, Marketing Managers and Country Managers from the region.
Clinical Sites:
Principal Investigators, Co-Investigators, Study Coordinators, Study Nurses and others involved in clinical research.
For more information:
Office address:
Panská 9
Bratislava 811 01
Slovak Republic
Postal address:
P.O. BOX 343
Bratislava 811 01
Slovak Republic
Office Phone: +421 232 662 621
(Business Hours 9am - 5:30pm Mon to Fri)
Office Fax: +421 232 662 622
After Hours: +421 910 328 806
E-mail: nextlevel(at)nextlevelpharma.com
or visit their website
Central & Eastern Europe continues to be one of the most attractive regions globally for running clinical trials. With its substantial pool of patients, centralized healthcare system and highly motivated investigators it still offers time, cost and quality advantages over other territories.
This event will build upon our previous meetings by examining in detail the current clinical landscape impacting clinical trials in the CEE & CIS region, dealing with longstanding regulatory obstacles, site selection and performance hurdles, approaches to ensure the quality and integrity of data and improving understanding of clinical trials amongst the region’s population. Particular attention will also be given to the continuing barriers to improvements in EU member states as well as Russia, Ukraine and the Balkan regions via focused conference sessions.
NextLevel Pharma's "Clinical Site Partnerships in Central & Eastern Europe" event is the only meeting which provides the opportunity to participate in 1 on 1 partnering sessions enabling trial sponsor companies, CROs, clinical solution providers, and sites themselves to meet with one another to discuss potential partnerships.
Central & Eastern Europe continues to be one of the most attractive regions globally for running clinical trials. With its substantial pool of patients, centralized healthcare system and highly motivated investigators it still offers time, cost and quality advantages over other territories.
This event will build upon our previous meetings by examining in detail the current clinical landscape impacting clinical trials in the CEE & CIS region, dealing with longstanding regulatory obstacles, site selection and performance hurdles, approaches to ensure the quality and integrity of data and improving understanding of clinical trials amongst the region’s population. Particular attention will also be given to the continuing barriers to improvements in EU member states as well as Russia, Ukraine and the Balkan regions via focused conference sessions.
NextLevel Pharma's "Clinical Site Partnerships in Central & Eastern Europe" event is the only meeting which provides the opportunity to participate in 1 on 1 partnering sessions enabling trial sponsor companies, CROs, clinical solution providers, and sites themselves to meet with one another to discuss potential partnerships.
Who will benefit:
Pharmaceutical & Biotechnology Organisations:
Global / European / Regional / Country Heads of Clinical Operations, Clinical Development, Outsourcing, Contract Management, Risk Management, R&D Sourcing, Business Development. Project Managers, Study Managers, and Senior CRAs,
CROs & Clinical Solution Providers:
CEOs, Business Development Directors, Product Managers, Marketing Managers and Country Managers from the region.
Clinical Sites:
Principal Investigators, Co-Investigators, Study Coordinators, Study Nurses and others involved in clinical research.
For more information:
Office address:
Panská 9
Bratislava 811 01
Slovak Republic
Postal address:
P.O. BOX 343
Bratislava 811 01
Slovak Republic
Office Phone: +421 232 662 621
(Business Hours 9am - 5:30pm Mon to Fri)
Office Fax: +421 232 662 622
After Hours: +421 910 328 806
E-mail: nextlevel(at)nextlevelpharma.com
or visit their website
0 comments
Post a Comment